Calumet Specialty Products Stock Investor Sentiment

CLMT Stock  USD 13.04  0.42  3.12%   
Slightly above 68% of Calumet Specialty's investor base is looking to short. The current sentiment regarding investing in Calumet Specialty Products stock implies that many traders are alarmed. Calumet Specialty's investing sentiment can be driven by a variety of factors including economic data, Calumet Specialty's earnings reports, geopolitical events, and overall market trends.
  

Calumet Specialty Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Calumet Specialty can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Calumet Specialty Maximum Pain Price Across May 16th 2025 Option Contracts

Calumet Specialty's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Calumet Specialty close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Calumet Specialty's options.
21 hours ago at gurufocus.com         
Calumet Inc to Participate in Wolfe Research Refining Conference
Gurufocus Stories at Macroaxis
a day ago at insidermonkey.com         
Here are Crossroads Capitals Updates on Calumet
insidermonkey News
a day ago at gurufocus.com         
Calumet Inc Shares Down 2.89 percent on Mar 3
Gurufocus Stories at Macroaxis
2 days ago at finance.yahoo.com         
Calumet Full Year 2024 Earnings EPS Beats Expectations
Yahoo News
2 days ago at thelincolnianonline.com         
Calumet Specialty Products Partners Posts Earnings Results, Beats Expectations By 0.59 EPS
news
few days ago at gurufocus.com         
Calumet Reports Fourth Quarter and Fiscal Year 2024 Results
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Calumet Announces Sale of Assets Related to Industrial Portion o
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Calumet Inc Retains Consumer Segment Amid Royal Purple Acquisition by Lubrication Engineers
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Calumet Inc Announces Sale of Industrial Assets of Royal Purple Business
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Calumet Inc Shares Gap Down to 14.22 on Feb 28
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
What To Expect From Calumet Inc Q4 2024 Earnings
Yahoo News
few days ago at gurufocus.com         
What To Expect From Calumet Inc Q4 2024 Earnings
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Wasserstein Debt Opportunities Management, L.P. Increases Stake in Calumet Inc.
Gurufocus Stories at Macroaxis
six days ago at www.macroaxis.com         
Acquisition by David Lunin of 37463 shares of Calumet Specialty subject to Rule 16b-3
Macroaxis News
over a week ago at Macroaxis         
Is Calumet Specialty (USA Stocks:CLMT) finally getting endorsement from private investors?
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Calumet Specialty that are available to investors today. That information is available publicly through Calumet media outlets and privately through word of mouth or via Calumet internal channels. However, regardless of the origin, that massive amount of Calumet data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Calumet Specialty news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Calumet Specialty relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Calumet Specialty's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Calumet Specialty alpha.

Calumet Specialty Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 8921 shares by Straumins Jennifer of Calumet Specialty subject to Rule 16b-3
12/04/2024
2
Calumet Specialty Products Partners Shares Gap Up Following Analyst Upgrade
01/15/2025
3
Calumet Inc Shares Up 4.86 percent on Jan 29
01/29/2025
4
Calumet Specialty Products Partners Trading Down 7.6 percent Should You Sell
02/05/2025
5
Calumet Inc Trading 16.72 percent Higher on Feb 12
02/12/2025
6
Calumet Specialty Products Partners Shares Down 5.9 percent Heres Why
02/13/2025
7
Calumet, Inc. to Release Fourth Quarter and Fiscal Year 2024 Earnings on February 28, 2025
02/14/2025
8
Calumet to Attend Raymond James Conference
02/19/2025
9
Calumet Inc to Attend Raymond James Institutional Investors Conference
02/20/2025
10
Acquisition by David Lunin of 37463 shares of Calumet Specialty subject to Rule 16b-3
02/25/2025
11
Wasserstein Debt Opportunities Management, L.P. Increases Stake in Calumet Inc.
02/26/2025
12
Calumet Announces Sale of Assets Related to Industrial Portion o
02/28/2025
13
Calumet Inc Shares Down 2.89 percent on Mar 3
03/03/2025

Additional Tools for Calumet Stock Analysis

When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.